VK Services, LLC

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), VK Services, LLC reported 5 stock positions worth $455.0 million. Its top holding was Rocket Lab USA (RKLB) at 80.9% of the portfolio, followed by Maplebear (CART, 16.7%) and Vicarious Surgical Class A (RBOT, 1.2%). Compared with Q2 2024, it opened 1 new position, sold out of 3, added to 1 and reduced 3. The biggest buy was a new position in Vicarious Surgical Class A (RBOT) and the biggest sale Maplebear (CART, shares −50%).

Most Recent 13F
Q2 2026
Location
Menlo Park, CA
CIK
0001501927
Portfolio Value
$455.0M (Q3 2024)
SEC Filing
0000950123-24-011810 ↗ filed Nov 14, 2024

Holdings Value

0$200.0M$400.0M$600.0M$800.0M$1.0B Q1 2024: $549.0M Q1 2024 Q2 2024: $409.7M Q2 2024 Q3 2024: $455.0M $455.0M Q3 2024 Q4 2024: $848.7M Q4 2024 Q1 2025: $387.6M Q1 2025 Q2 2025: $770.0M Q2 2025 Q3 2025: $404.3M Q3 2025 Q4 2025: $2.9M Q4 2025 Q1 2026: $543K Q1 2026 Q2 2026: $1.0M Q2 2026

Holdings 5 stocks · $455.0M

RKLB Rocket Lab USA Inc. 80.88% 37,823,617 $368.0M Reduce -27.3%
CART Maplebear Inc. 16.75% 1,870,529 $76.2M Reduce -49.8%
RBOT Vicarious Surgical Inc. Class A 1.20% 965,204 $5.5M New
AFRM Affirm Holdings Inc. 0.67% 75,000 $3.1M Add +0.0%
PACB Pacific Biosciences of Calif 0.49% 1,316,393 $2.2M Reduce -50.0%

Portfolio Sells Q2 2024 → Q3 2024

CART Maplebear Inc. Reduce -49.8% 16.75% −12.51
LANZATECH GLOBAL INC Sold out 0.00% −6.27
VICARIOUS SURGICAL INC Sold out 0.00% −1.38
VELO3D INC Sold out 0.00% −0.70
PACB Pacific Biosciences of Calif Reduce -50.0% 0.49% −0.39
RKLB Rocket Lab USA Inc. Reduce -27.3% 80.88% +19.92

Portfolio Buys Q2 2024 → Q3 2024

RBOT Vicarious Surgical Inc. Class A New 1.20% +1.20
AFRM Affirm Holdings Inc. Add +0.0% 0.67% +0.12

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$1.0MVELO
Q1 2026 1$543KVELO
Q4 2025 2$2.9MRBOT, VELO
Q3 2025 3$404.3MRKLB, RBOT, VELO
Q2 2025 2$770.0MRKLB, RBOT
Q1 2025 2$387.6MRKLB, RBOT
Q4 2024 2$848.7MRKLB, RBOT
Q3 2024 5$455.0MRKLB, CART, RBOT, AFRM, PACB
Q2 2024 7$409.7MRKLB, CART, LANZATECH GLOBAL INC, VICARIOUS SURGICAL INC, PACB
Q1 2024 7$549.0MRKLB, CART, LANZATECH GLOBAL INC, VELO3D INC, PACB